Citius Oncology (CTOR) Cash from Investing Activities (2023 - 2026)

Citius Oncology's Cash from Investing Activities history runs 4 years deep, the most recent figure standing at -$600000.0 for Q1 2026.

• In Q1 2026, Cash from Investing Activities changed N/A year-over-year to -$600000.0; the TTM figure through Mar 2026 stood at $19.8 million (changed N/A YoY), while the FY2025 annual figure was -$5.8 million, down 15.0% from the prior year.
• Cash from Investing Activities was -$600000.0 for Q1 2026 at Citius Oncology, up from -$4.4 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $24.7 million in Q1 2024 to a low of -$4.4 million in Q4 2025.
• Historically, Cash from Investing Activities has averaged $3.8 million across 4 years, with a median of -$600000.0 in 2026.